The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001623:Betamethasone / Q000008:administration & dosage / Q000494:pharmacology; D001808:Blood Vessels / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004655:Emulsions; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone; D009824:Ointments; D010592:Pharmaceutic Aids; D010919:Placebos; D012867:Skin / Q000098:blood supply* / Q000187:drug effects; D014222:Triamcinolone Acetonide / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D004655:Emulsions; D009824:Ointments; D010592:Pharmaceutic Aids; D010919:Placebos; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone